|
⚲
|
| Keyboard |
| Osborn John E
✚
|
|
|---|---|
| CIK # | 0001209721 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001209721] | |
| 4 | [0001209721] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zyla Life Sciences | |
| Osborn John E | |
| Onyx Pharmaceuticals Inc | |
| Dendreon Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Disposed to issuer | 75,000 | ||
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Disposed to issuer | 58,133 | ||
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Disposed to issuer | 29,666 | ||
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Disposed to issuer | 10,000 | ||
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2019-01-31 | Disposed to issuer | 20,000 | ||
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2018-05-14 | Grant | 75,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2017-06-08 | Grant | 58,133 | $0.00 | |
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2016-06-15 | Grant | 29,666 | $0.00 | |
|
Zyla Life Sciences EGLT
Common Stock (Right to Buy) · derivative
|
2015-06-10 | Grant | 10,000 | $0.00 | |
|
Zyla Life Sciences EGLT
Stock Option (Right to Buy) · derivative
|
2015-04-10 | Grant | 20,000 | $0.00 | |
|
Onyx Pharmaceuticals Inc ONXX
Common Stock
|
2012-06-01 | Grant | 11,000 | $0.00 | |
|
Onyx Pharmaceuticals Inc ONXX
Stock Option (Right to Buy) · derivative
|
2012-06-01 | Grant | 87,360 | $0.00 | |
|
Dendreon Corp DNDN
Common Stock
|
2012-01-03 | Grant | 150,000 | $0.00 |